Distinguishing Bladder Cancer from Cystitis Patients Using Deep Learning

Urinary tract cancers are considered life-threatening conditions worldwide, and Bladder Cancer is one of the most malignant urinary tract tumors, with an estimated number of more than 1.3 million cases worldwide each year. Bladder Cancer is a heterogeneous disease; the main symptom is painless hematuria. However, patients with Bladder Cancer may initially be misdiagnosed as Cystitis or infection, and cystoscopy alone may sometimes be misdiagnosed as urolithiasis or Cystitis, thereby delaying medical attention. Early diagnosis of Bladder Cancer is the key to successful treatment. This study uses six deep learning methods through different oversampling techniques and feature selection, and then through dimensionality reduction techniques, to establish a set that can effectively distinguish between Bladder Cancer and Cystitis patient’s deep learning model. The research results show that based on the laboratory clinical dataset, the deep learning model proposed in this study has an accuracy rate of 89.03% in distinguishing between Bladder Cancer and Cystitis, surpassing the results of previous studies. The research model developed in this study can be provided to clinicians as a reference to differentiate between Bladder Cancer and Cystitis.